Article Information
History
- September 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marcus Skribek1,2,*,
- Maria-Effrosyni Livanou3,
- Ioannis Vathiotis3,
- Viktor Strandman1,2,
- Axel Thorell2,
- Andreas Koulouris1,2,4,
- Konstantinos Syrigos3,
- Simon Ekman1,2,# and
- Georgios Tsakonas1,2,#
- 1Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- 2Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
- 3Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece
- 4Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, Greece
- ↵*Corresponding author: Dr. Marcus Skribek, MD, Department of Oncology-Pathology, Karolinska Institutet, Solnavägen 1, 171 77, Stockholm, Sweden / Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Eugeniavägen 3, 171 76, Stockholm, Sweden. Email: marcus.skribek{at}ki.se.
Posted September 24, 2024.
The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain Metastases
